Australia markets open in 2 hours 54 minutes

Biotage AB (publ) (0GRP.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
216.59+4.79 (+2.26%)
At close: 05:13PM BST
Currency in SEK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 3-31.75%
S&P500 52-week change 329.31%
52-week high 3215.00
52-week low 3104.80
50-day moving average 3121.61
200-day moving average 3143.66

Share statistics

Avg vol (3-month) 313.6k
Avg vol (10-day) 39.72k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 865.96M
% held by insiders 10.45%
% held by institutions 180.42%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.60
Trailing annual dividend yield 30.76%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 11.91%
Operating margin (ttm)12.92%

Management effectiveness

Return on assets (ttm)5.78%
Return on equity (ttm)8.46%

Income statement

Revenue (ttm)1.98B
Revenue per share (ttm)25.61
Quarterly revenue growth (yoy)33.00%
Gross profit (ttm)N/A
EBITDA 460M
Net income avi to common (ttm)236M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)-23.30%

Balance sheet

Total cash (mrq)683M
Total cash per share (mrq)8.54
Total debt (mrq)257M
Total debt/equity (mrq)6.61%
Current ratio (mrq)2.16
Book value per share (mrq)48.61

Cash flow statement

Operating cash flow (ttm)381M
Levered free cash flow (ttm)357.42M